XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Sales:    
Product $ 3,087,984 $ 3,475,171
Engineering development contracts   348,876
Returns and allowances   (458,181)
Total net sales 3,087,984 3,365,866
Cost of sales:    
Product 1,593,268 1,740,703
Engineering development contracts   87,349
Total cost of sales 1,593,268 1,828,052
Gross profit 1,494,716 1,537,814
Operating expenses:    
Research and development 923,721 1,085,988
Selling, general and administrative 1,622,555 2,047,121
Total operating expenses 2,546,276 3,133,109
Operating loss (1,051,560) (1,595,295)
Interest income 9,624 9,876
Other income 21,431 19,114
Loss before income taxes (1,020,505) (1,566,305)
Income tax benefit (138,886) (371,331)
Net loss $ (881,619) $ (1,194,974)
Net loss per common share:    
Basic (in dollars per share) $ (0.05) $ (0.07)
Diluted (in dollars per share) $ (0.05) $ (0.07)
Weighted average shares outstanding:    
Basic (in shares) 16,783,129 16,716,014
Diluted (in shares) 16,783,129 16,716,014